Laparoscopic donor nephrectomy

Gupta, Nitin; Raina, Pamposh; Kumar, Anant

doi:10.4103/0972-9941.19262

Cited by 15 publications

(6 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This technique has become one of the most frequently performed surgeries due to its favorable outcomes, including reduced postoperative complications, decreased pain, shorter hospital stays, and improved cosmetic appearance when compared to open surgery. Despite some reported postoperative complications, chylous ascites is among the least frequently reported [ 4 ]. While this condition has been rarely reported in several countries, this is the first documented case from our region.…”

Section: Introductionmentioning

confidence: 99%

Chylous Ascites Following Laparoscopic Donor Nephrectomy: A Case Report

Buksh¹,

Almalki²,

Jar³

et al. 2023

Cureus

View full text Add to dashboard Cite

Chylous ascites is a form of peritoneal fluid accumulation that can arise from trauma or lymphatic obstruction. In this report, we present the first case of chylous ascites following laparoscopic donor nephrectomy in our high-volume kidney transplant center. The patient presented to the emergency department three weeks post-procedure with complaints of abdominal distention and discomfort, accompanied by constipation and nausea. Radiological confirmation of ascites was followed by paracentesis, which yielded 20 mL of milky fluid that was analyzed and confirmed as chylous ascites. A subsequent pigtail drain was inserted, resulting in a total drainage of 4 L of fluid. Chylous ascites is a rare complication of abdominal surgeries, with higher body mass index and the American Society of Anesthesiologists physical status score system being significant risk factors. Conservative management involving diet modification is the initial therapy, with percutaneous drainage or more aggressive surgical interventions considered if conservative measures are not effective, with high success rates reported for these interventions. Here, we report a case of chylous ascites following donor nephrectomy as the first case reported from our region.

show abstract

Section: Introductionmentioning

confidence: 99%

Chylous Ascites Following Laparoscopic Donor Nephrectomy: A Case Report

Buksh¹,

Almalki²,

Jar³

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…4 Nowadays, laparoscopic donor nephrectomy is considered the standard of care with the advantages of minimally invasive surgery, including reduced blood loss, reduced pain, reduced hospital convalescence and improved cosmetic results, when compared to open surgery. [4][5][6][7] Robotic-assisted laparoscopic donor nephrectomy (RALDN) is reported to further optimize minimally invasive surgery with the added benefits of three-dimensional magnified vision, intuitive dissection movement and better surgical ergonomics. 8,9 However, whether the donor's outcomes in RALDN are better than in conventional laparoscopic approach is still under debate.…”

Section: Introductionmentioning

confidence: 99%

“…Living donation plays an essential role in global kidney transplantation, 1 especially in Asian countries 2,3 . Expanding the use of kidneys from living donors requires a constant push to optimize the living donor nephrectomy surgery 4 …”

Section: Introductionmentioning

confidence: 99%

“…2,3 Expanding the use of kidneys from living donors requires a constant push to optimize the living donor nephrectomy surgery. 4 The procedure of living donor nephrectomy is a delicate surgery that requires careful preparation and reproducible technique to achieve optimal outcomes for both the donor and recipient. 4 Nowadays, laparoscopic donor nephrectomy is considered the standard of care with the advantages of minimally invasive surgery, including reduced blood loss, reduced pain, reduced hospital convalescence and improved cosmetic results, when compared to open surgery.…”

Section: Introductionmentioning

confidence: 99%

“…4 The procedure of living donor nephrectomy is a delicate surgery that requires careful preparation and reproducible technique to achieve optimal outcomes for both the donor and recipient. 4 Nowadays, laparoscopic donor nephrectomy is considered the standard of care with the advantages of minimally invasive surgery, including reduced blood loss, reduced pain, reduced hospital convalescence and improved cosmetic results, when compared to open surgery. [4][5][6][7] Robotic-assisted laparoscopic donor nephrectomy (RALDN) is reported to further optimize minimally invasive surgery with the added benefits of three-dimensional magnified vision, intuitive dissection movement and better surgical ergonomics.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Introducing robot‐assisted laparoscopic donor nephrectomy after experience in retroperitoneal endoscopic approach: a matched propensity score analysis

Thái

Chau

Hoang

et al. 2021

ANZ Journal of Surgery

View full text Add to dashboard Cite

Objectives: To assess the safety and efficacy of introducing robotic-assisted laparoscopic donor nephrectomy (RALDN) to the standard retroperitoneal endoscopic donor nephrectomy (REDN). Methods: Data were collected prospectively from 124 consecutive living kidney donors (93 for REDN subgroup and 31 for RALDN subgroup) from February 2018 to December 2020. Donor baseline demographics, perioperative outcomes and recipient outcomes were recorded, and these parameters were compared between the two subgroups before and after propensity-score matching. Results: Mean age was 51.1 AE 9.1 years; 42.7% were males; mean body mass index was 22.7 AE 2.4; and there were 109 (88%) left kidneys. The following data of REDN and RALDN was, respectively, recorded: operative time (213 AE 43 versus 216 AE 39 min, p = 0.721), warm ischemic time (4.7 AE 1.2 versus 4.9 AE 1.4 min, p = 0.399), postoperative complications (5.4% versus 6.5%, p = 1), haemoglobin (g/L) drop (9.4 AE 7.2 versus 9.7 AE 6.6, p = 0.836), blood creatinine at 6 month (1.15 AE 0.23 versus 1.13 AE 0.24 mg/dL, p = 0.734) and at 1 year (1.09 AE 0.22 versus 1.17 AE 0.28 mg/dL, p = 0.591). In postpropensity score matched analyses, there was no significant differences between the two groups including intraoperative and postoperative complications. Conclusions: RALDN could be safely introduced into a living donor program experienced in laparoscopic donor nephrectomy. The outcomes of our study comparing these minimally invasive techniques are mostly similar in terms of intraoperative and postoperative outcomes for kidney donors.Abbreviations: ASA American society of anesthesiologists; BMI body mass index; eGFR estimated glomerular filtration rate; HLA Human Leukocyte Antigens; RALDN Robotic-assisted laparoscopic donor nephrectomy; REDN Retroperitoneal endoscopic donor nephrectomy; SCr serum creatinine.Bold values are p-value less than 0.05 and are considered statistically significant.

show abstract